ASHLEY ROZEVELD: Open Payments
NPI 1518620293 · GRANT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 35 payments from 16 companies in 2025. Trend: 2023 $192 · 2024 $597 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $73 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Esperion Therapeutics, Inc. | 3 | $51 |
| Novo Nordisk Inc | 3 | $47 |
| Amgen Inc. | 2 | $43 |
| PFIZER INC. | 2 | $42 |
| Astellas Pharma US Inc | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
Products named: UBRELVY, AIRSUPRA, CAPLYTA, TRELEGY ELLIPTA, NEXLETOL, NURTEC ODT, Ozempic, REPATHA.
Industry payments across MI — which companies pay providers there.
